TABLE OF CONTENTS
| | | | Volume 5, April 2015 | | In this issue Reviews Original Articles Letters to the Editor
| | | | | Advertisement | | 2013 IMPACT FACTOR 2.884
Blood Cancer Journal is an online-only, open access journal seeking to publish articles of the highest quality concerning hematologic malignancies and related disorders.
Explore the benefits of submitting your next research article: http://bit.ly/1FpVSOx | | | | | | Reviews | Top | | Haematological cancer and quality of life: a systematic literature reviewP Allart-Vorelli, B Porro, F Baguet, A Michel and F Cousson-Gélie Blood Cancer J 2015 5: e305; 10.1038/bcj.2015.29 Abstract | Full Text | | | | Acute promyelocytic leukemia: where did we start, where are we now, and the futureC C Coombs, M Tavakkoli and M S Tallman Blood Cancer J 2015 5: e304; 10.1038/bcj.2015.25 Abstract | Full Text | | | | The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapiesT Dosani, M Carlsten, I Maric and O Landgren Blood Cancer J 2015 5: e306; 10.1038/bcj.2015.32 Abstract | Full Text | | Original Articles | Top | | Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemiaA Eriksson, A Österroos, S Hassan, J Gullbo, L Rickardson, M Jarvius, P Nygren, M Fryknäs, M Höglund and R Larsson Blood Cancer J 2015 5: e307; 10.1038/bcj.2015.31 Abstract | Full Text | | | | Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaborationJ C Huang, S K Basu, X Zhao, S Chien, M Fang, V G Oehler, F R Appelbaum and P S Becker Blood Cancer J 2015 5: e302; 10.1038/bcj.2015.17 Abstract | Full Text | | | | Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell developmentE N Smith, E M Ghia, C M DeBoever, L Z Rassenti, K Jepsen, K-A Yoon, H Matsui, S Rozenzhak, H Alakus, P J Shepard, Y Dai, M Khosroheidari, M Bina, K L Gunderson, K Messer, L Muthuswamy, T J Hudson, O Harismendy, C L Barrett, C H M Jamieson, D A Carson, T J Kipps and K A Frazer Blood Cancer J 2015 5: e303; 10.1038/bcj.2015.14 Abstract | Full Text | | Letters to the Editor | Top | | Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteinsM Dwojak, M Bobrowicz, J Bil, K Bojarczuk, B Pyrzynska, M Siernicka, A Malenda, E Lech-Maranda, W Tomczak, K Giannopoulos, J Golab and M Winiarska Blood Cancer J 2015 5: e300; 10.1038/bcj.2015.27 Full Text | | | | Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocationY Nakamura, H Kayano, E Kakegawa, H Miyazaki, T Nagai, Y Uchida, Y Ito, N Wakimoto, S Mori and M Bessho Blood Cancer J 2015 5: e301; 10.1038/bcj.2015.26 Full Text | | | | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patientsT Tao, X Ma, J Yang, J-Y Zou, S-M Ji, Y-S Tan, W Gong, F Du, J Xu, C-M Ye, X-W Tang, D-P Wu and S-L Xue Blood Cancer J 2015 5: e308; 10.1038/bcj.2015.33 Full Text | | | | | Advertisement | | Reach the widest possible audience in the shortest possible time
Scientific Reports is the home for rapidly published, highly visible open access research. Multi-disciplinary in scope, we?re open to all, publishing sound original research papers across the sciences without barriers to access.
What can we do for your research? | | | | | | You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment